Evidence map›Paper›PMID 41541420›Full record

ReviewJHLT open2026

Lung transplantation for chronic thromboembolic pulmonary hypertension.

Laurent Godinas, Michaela Orlitová, Emanuele Muscogiuri, Laurens Ceulemans, Elie Fadel, Marion Delcroix, Tom Verbelen

Abstract readReview
In one paragraph

Review in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laurent GodinasDepartment of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Michaela OrlitováDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Emanuele MuscogiuriDepartment of Radiology, University Hospitals Leuven, Leuven, Belgium.
Laurens CeulemansLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Elie FadelThoracic Surgery and Transplantation Department, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France.
Marion DelcroixDepartment of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Tom VerbelenDepartment of Cardiovascular Sciences, KULeuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic advances in chronic thromboembolic pulmonary hypertension (CTEPH) over the last 10 years have improved patient prognosis. As a result, the role of lung transplantation (LTx) for this indication has been greatly reduced. In this review article, we describe the evolution of treatments for CTEPH, the place that remains for lung transplantation, and the particularities of lung transplantation for this indication.

Indexed as

Balloon pulmonary angioplastyChronic thromboembolic pulmonary hypertensionLung transplantationPulmonary endarterectomyPulmonary hypertension

Identifiers

PMID41541420
PMCPMC12800618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.